As the CCO for North America I oversee and engage in all ethics and/or compliance matters related to the commercialization of Lilly products across all therapeutic areas and functions including Medical, Marketing, and Sales. In this role my direct reports include investigations, monitoring, sample accountability, and the overall build and execution of the Lilly USA risk assessment and resulting monitoring and measurement plan. I am a voting member of the LillyUSA Board of Governors.

Responsible for building and leading a new sales force responsible for the launch of novel molecules for the treatment of Migraine and Pain. Key deliverables include building a high performing management and sales team, lead the development and execution of marketing strategy, define and set strategy for customer value creation, identify and build core execution capabilities, and achieve business results within allocated budget and resource models.

Responsible for providing compliance guidance on overall business strategies, decisions, and activities within the business unit and as defined by the Office on the Inspector General. Served as the primary point of contact for all global medical affairs and marketing teams. Coordinated with these teams, promoting products in more than 120 different countries around the globe. Worked cross functionally with Legal, Human Resources, and corporate alliance partners to ensure alignment with global policies and procedures and launch excellence with high integrity and high performance.

Responsible for leading up to 150+ Sales Representatives and District Sales Managers across 50% nation. Selling environment includes retail and Hospital Accounts. Strong understanding of Payer/IDN influences. Responsible for P+L with portfolio sales exceeding $500M across CV and Diabetes portfolio. * Exceeded portfolio sales plan in 2016, 2015, 2014 (and 7 of 8 years)* Recognized for development of talent into positions of greater responsibility* Creation of key resources used across USA affiliate to maximize profit and resource allocation.

Led strategic initiative for development of new sales force (n=475) and new product launch in Cardiovascular area. Responsible for activities associated with sales force sizing and deployment, incentives, and operational execution. Worked cross functionally with internal business functions and external Alliance partners to prepare for product launch.

Led and managed 123 sales representatives and 10 district sales managers. Markets included hospitals, long term care facilities, community mental health centers, private psychiatry, primary care, neurology, endocrinology and pain specialists. Product portfolio included Zyprexa®, Strattera® and the launch of Cymbalta®, Symbyax®, Zyprexa Intramuscular®, Zyprexa Zydis®. * Share of Market for all promoted products exceeded regional and national Average .* Selected as international coaching partner with Eli Lilly Italian Affiliate, Sesto, Italy, 4Q06.* Six Sigma Trained Greenbelt responsible for several initiatives across affiliate. * Consistently promoted 15% of sales personnel to positions of greater responsibility.

Managed, coached and lead a team of 10-16 primary care sales representatives in driving sales of a neuroscience-focused portfolio of products including Prozac (Depression), Prozac Weekly, Zyprexa (Bipolar Mania), Strattera (ADHD) and Evista (Osteoporosis).* Consistently ranked in top 20% of national sales performance * Awarded 2001, 2002 and 2003 Coaching Award of Excellence.

Supported the National Hospital Group Purchasing Organization Business Unit ($130M annual revenue) with emphasis on contract negotiation strategy and marketing.* Performed contract and account analysis to ensure profitability and compliance to regulations.* Supported contracting initiatives for 9 sales representatives and 3 account managers.

Ensured minimum profitability and performance for individual agreements worth $100M in the Northeast and South-central areas.* Supported 17 sales representatives and 2 sales managers in business case development. profitability analysis, and strategic marketing.* Managed legal issues including Medicaid best price and anti-trust.

Responsible for the promotion and sale of fluoxetine hydrochloride (Prozac) within pilot physician based (psychiatric) sales territory.* Created job description, performance parameters, and daily promotional activities.* Coordinated sales and marketing efforts for 10 sales representatives.* Implemented physician based symposia and educational programs across 5 geographies.* #1 regional performer – Prozac SOM growth, quota award recipient, 120.3% to plan.

Promoted four products within territory. Communicated a thorough knowledge of disease state management and current medical therapy in a manner consistent with FDA regulations. 1993 - Recipient of Prozac Sales Incentive Program award.1992 – Recipient of National Perk Sales award, Washington, D.C.1991 – Recipient of National Recognition Sales Award, San Diego, CA.1990 – Recipient of Southern Region Rookie of the Year.